4basebio PLC, headquartered in Great Britain, is a pioneering biotechnology company specialising in the development of innovative solutions for the life sciences sector. Founded in 2018, 4basebio has quickly established itself as a leader in the field of DNA-based products and services, focusing on areas such as gene therapy and synthetic biology. The company’s core offerings include high-quality DNA synthesis and advanced genomic services, which are distinguished by their precision and scalability. With a commitment to enhancing research and therapeutic applications, 4basebio has achieved significant milestones, including strategic partnerships and advancements in DNA manufacturing technologies. As a key player in the biotechnology industry, 4basebio PLC continues to drive innovation and contribute to the evolving landscape of genetic research and development.
How does 4basebio PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
4basebio PLC's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
4basebio PLC, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that 4basebio PLC may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for companies like 4basebio to establish clear climate commitments and reduction initiatives to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
4basebio PLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
